Private equity acquisitions of methadone clinics impact patient access

Private equity firms are increasingly acquiring methadone clinics, a trend that has not improved access to the medication used to treat opioid addiction. While methadone can reduce the risk of a fatal overdose by approximately half, federal estimates indicate that only 22% of individuals with opioid use disorder receive the treatment.

In rural areas, such as Bisbee Junction, Arizona, patients face significant logistical hurdles. Strict clinic hours and long travel distances often force patients to navigate difficult schedules to receive doses. For those relying on Medicaid-provided transportation, delays can result in missed doses, which poses serious risks to recovery.

For over fifty years, methadone has been dispensed exclusively through specialized, government-approved opioid treatment programs rather than through regular doctors or pharmacies. This regulatory structure, combined with the current shift in clinic ownership, continues to present barriers for those seeking lifesaving treatment.